Shenzhen Salubris Pharmaceuticals Co Ltd Net Asset Momentum
Shenzhen Salubris Pharmaceuticals Co Ltd net asset momentum. Shenzhen Salubris Pharmaceuticals Co Ltd (002294) recorded a net asset momentum of 8.7% as of December 2024, with net assets of CN¥8.75 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 002294 total equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Net asset momentum of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. This chart tracks Shenzhen Salubris Pharmaceuticals Co Ltd's year-over-year net asset growth across 19 annual reporting periods from 2006 to 2024. The most recent momentum reading is +8.7%, with net assets of CN¥8.75 Billion CNY as of December 2024. Check tangible equity quality of Shenzhen Salubris Pharmaceuticals Co Ltd to evaluate the tangible quality of the company's equity base.
Shenzhen Salubris Pharmaceuticals Co Ltd Net Asset Momentum by Year (2006–2024)
Shenzhen Salubris Pharmaceuticals Co Ltd net asset momentum by year from 2006 to 2024. The table below shows the complete annual net asset history for Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 002294 company net worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥8.75 Billion | CN¥10.47 Billion | CN¥1.71 Billion | ▲ +8.7% |
| 2023 | CN¥8.06 Billion | CN¥9.40 Billion | CN¥1.34 Billion | ▲ +1.0% |
| 2022 | CN¥7.98 Billion | CN¥9.76 Billion | CN¥1.78 Billion | ▼ -0.9% |
| 2021 | CN¥8.05 Billion | CN¥9.24 Billion | CN¥1.20 Billion | ▲ +43.9% |
| 2020 | CN¥5.59 Billion | CN¥6.92 Billion | CN¥1.33 Billion | ▼ -16.1% |
| 2019 | CN¥6.67 Billion | CN¥7.73 Billion | CN¥1.07 Billion | ▼ -3.0% |
| 2018 | CN¥6.87 Billion | CN¥7.90 Billion | CN¥1.03 Billion | ▲ +11.6% |
| 2017 | CN¥6.16 Billion | CN¥6.86 Billion | CN¥705.86 Million | ▲ +12.8% |
| 2016 | CN¥5.46 Billion | CN¥6.53 Billion | CN¥1.07 Billion | ▲ +16.3% |
| 2015 | CN¥4.70 Billion | CN¥5.39 Billion | CN¥691.25 Million | ▲ +24.0% |
| 2014 | CN¥3.79 Billion | CN¥4.62 Billion | CN¥827.95 Million | ▲ +20.8% |
| 2013 | CN¥3.13 Billion | CN¥3.64 Billion | CN¥508.36 Million | ▲ +20.3% |
| 2012 | CN¥2.61 Billion | CN¥2.98 Billion | CN¥374.02 Million | ▲ +22.1% |
| 2011 | CN¥2.13 Billion | CN¥2.45 Billion | CN¥310.52 Million | ▲ +14.4% |
| 2010 | CN¥1.87 Billion | CN¥2.17 Billion | CN¥309.50 Million | ▲ +14.9% |
| 2009 | CN¥1.62 Billion | CN¥1.77 Billion | CN¥148.59 Million | ▲ +517.5% |
| 2008 | CN¥262.90 Million | CN¥408.60 Million | CN¥145.70 Million | ▲ +80.1% |
| 2007 | CN¥145.96 Million | CN¥255.94 Million | CN¥109.98 Million | ▲ +37.1% |
| 2006 | CN¥106.48 Million | CN¥158.66 Million | CN¥52.19 Million | — |